Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Retrograde nerve growth factor signaling abnormalities in familial dysautonomia
Lin Li, Katherine Gruner, Warren G. Tourtellotte
Lin Li, Katherine Gruner, Warren G. Tourtellotte
View: Text | PDF
Research Article Cell biology Neuroscience

Retrograde nerve growth factor signaling abnormalities in familial dysautonomia

  • Text
  • PDF
Abstract

Familial dysautonomia (FD) is the most prevalent form of hereditary sensory and autonomic neuropathy (HSAN). In FD, a germline mutation in the Elp1 gene leads to Elp1 protein decrease that causes sympathetic neuron death and sympathetic nervous system dysfunction (dysautonomia). Elp1 is best known as a scaffolding protein within the nuclear hetero-hexameric transcriptional Elongator protein complex, but how it functions in sympathetic neuron survival is very poorly understood. Here, we identified a cytoplasmic function for Elp1 in sympathetic neurons that was essential for retrograde nerve growth factor (NGF) signaling and neuron target tissue innervation and survival. Elp1 was found to bind to internalized TrkA receptors in an NGF-dependent manner, where it was essential for maintaining TrkA receptor phosphorylation (activation) by regulating PTPN6 (Shp1) phosphatase activity within the signaling complex. In the absence of Elp1, Shp1 was hyperactivated, leading to premature TrkA receptor dephosphorylation, which resulted in retrograde signaling failure and neuron death. Inhibiting Shp1 phosphatase activity in the absence of Elp1 rescued NGF-dependent retrograde signaling, and in an animal model of FD it rescued abnormal sympathetic target tissue innervation. These results suggest that regulation of retrograde NGF signaling in sympathetic neurons by Elp1 may explain sympathetic neuron loss and physiologic dysautonomia in patients with FD.

Authors

Lin Li, Katherine Gruner, Warren G. Tourtellotte

×

Figure 5

Elp1 maintains TrkA phosphorylation by negatively regulating Shp1 phosphatase activity.

Options: View larger image (or click on image) Download as PowerPoint
Elp1 maintains TrkA phosphorylation by negatively regulating Shp1 phosph...
(A) Shp1 and Elp1 recruitment to a protein complex containing TrkA in TCtl neurons is NGF-dependent and binding of Shp1 to TrkA is independent of Elp1 (results representative of n = 3 replicates). (B) Although no detectable differences in total phosphatase activity were identified between TCtl and TcKO neurons, immunoprecipitation of Shp1 showed it was significantly hyperactivated in the absence of Elp1 in TcKO neurons compared with TCtl neurons (Student’s t test; *P < 0.00001, n = 4). (C) Adenovirus-mediated expression of a short hairpin RNA (shShp1) reduced the level of Shp1 protein more than 80% relative to expression of a scrambled (shScr) shRNA in TCtl neurons. (D) Whereas TcKO neurons expressing shScr showed significant retrograde NGF-dependent survival abnormalities (Student’s t test; *P < 0.001, n = 3–6), expression of shShp1 significantly and completely rescued retrograde NGF-dependent survival (Student’s t test; **P < 0.000001, n = 4). (E) Accordingly, the level of retrograde pTrkA in cell bodies was highly decreased in TcKO neurons compared with TCtl neurons infected with adenovirus expressing shScr (Student’s t test; *P < 0.000005, n = 28) and it was completely rescued by infection with shShp1-expressing adenovirus (Student’s t test; **P < 0.0001, n = 11; arrowheads, results represent pTrkA fluorescence). Scale bars: 25 μM. For D and E, the results were considered significant if the Bonferroni’s corrected P value was less than 0.017.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts